Buildit, how many times does this need to happen?
Post# of 36537
https://storage.googleapis.com/wzukusers/user...5_2019.pdf
Generex Biotechnology Announces Merger with Public Vehicle for Public
Trading of NuGenerex Immuno-Oncology
Quote:
Generex Biotechnology Corporation
(www.generex.com) (OTCQB:GNBT) today announced a merger transaction with a public
company that is DTC eligible and current with its SEC filings to serve as a vehicle for the
quotation of the common stock of its subsidiary NuGenerex Immuno-Oncology (NGIO) as
an independent, publicly traded company. Generex is in the process of finalizing its
annual report on Form 10-K, which will be filed in the coming days . The Form 10-K will
include the audited financial statements for the legal documentation and Super Form 8-
K filing for the merger of NGIO with the public vehicle. We expect that NuGenerex
Immuno-Oncology will be quoted on a public exchange by the end of November , and the
1:4 shareholder dividend that was paid to Generex shareholders in February 2019 will be
converted into public shares shortly thereafter.